HER2-Negative Breast Cancer Completed Phase 2 Trials for Cyclophosphamide (DB00531)

DBCOND0072181 (HER2-Negative Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01705691Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast CancerTreatment
NCT01818063Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast CancerTreatment